|
Menopause with Mary Jane Minkin: HRT For Menopause Management in Benign Patients |
|
Enduring |
|
$0.00 |
|
The Big Reveal: 2020 State of the Society Survey- Patterns, Progress and Pathways to your Professional Future |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking - ASCO 2024 |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support: Cervical, Vulvar and Vaginal Cancer Resources - Preparing for the ABOG Oral Exam (Part 6) |
|
Enduring |
|
$0.00 |
|
SGO 2022 Winter Meeting |
|
Enduring |
|
$0.00 |
|
Health Equity in the COVID-19 Era: Understanding the Data and Strategies to Support Vulnerable Populations |
|
Enduring |
|
$0.00 |
|
Scientific Plenary III: Farr Nezhat Surgical Innovation Session |
|
Enduring |
|
$0.00 |
|
Session 6: Considerations and Risks for Gynecologic and Breast/Chest Cancers in Transgender Patients |
|
Enduring |
|
$0.00 |
|
SGO Talent Show |
|
Enduring |
|
$0.00 |
|
Education Forum I: Your Coding Questions Answered |
|
Enduring |
|
$0.00 |
|
SGO Wellness Curriculum |
|
Enduring |
|
$0.00 |
|
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Administration (Part 2) |
|
Enduring |
|
$0.00 |
|
SGO/ACCC Antineoplastic Flashcards |
|
Enduring |
|
$0.00 |
|
Use of PARPi in Gynecologic Oncology |
|
Enduring |
|
$0.00 |
|
Immunotherapy Part 3: Common Controversies and Remaining Questions |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward